107 related articles for article (PubMed ID: 11187896)
21. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
22. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
[TBL] [Abstract][Full Text] [Related]
23. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
[TBL] [Abstract][Full Text] [Related]
24. Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage.
Joswig H; Korte W; Früh S; Epprecht L; Hildebrandt G; Fournier JY; Stienen MN
Neurosurg Rev; 2018 Apr; 41(2):605-614. PubMed ID: 28890998
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.
Andreasen N; Minthon L; Clarberg A; Davidsson P; Gottfries J; Vanmechelen E; Vanderstichele H; Winblad B; Blennow K
Neurology; 1999 Oct; 53(7):1488-94. PubMed ID: 10534256
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.
Ishiguro K; Ohno H; Arai H; Yamaguchi H; Urakami K; Park JM; Sato K; Kohno H; Imahori K
Neurosci Lett; 1999 Jul; 270(2):91-4. PubMed ID: 10462105
[TBL] [Abstract][Full Text] [Related]
27. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
Chang CS; Liu HW; Lin SF; Chen TP
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
[TBL] [Abstract][Full Text] [Related]
28. CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease.
Liguori C; Stefani A; Sancesario G; Sancesario GM; Marciani MG; Pierantozzi M
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):655-9. PubMed ID: 25121572
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
Terzi M; Birinci A; Cetinkaya E; Onar MK
Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
[TBL] [Abstract][Full Text] [Related]
30. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.
Nishimura T; Takeda M; Nakamura Y; Yosbida Y; Arai H; Sasaki H; Shouji M; Hirai S; Khise K; Tanaka K; Hamamoto M; Yamamoto H; Matsubayashi T; Urakami K; Adachi Y; Nakashima K; Toji H; Nakamura S; Yoshida H
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):227-35. PubMed ID: 9646285
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
[TBL] [Abstract][Full Text] [Related]
32. [Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease].
Arai H; Satoh K; Terajima M; Nakagawa T; Higuchi M; Kosaka Y; Zhu C; Sasaki H
Nihon Ronen Igakkai Zasshi; 1996 Sep; 33(9):669-75. PubMed ID: 8940864
[TBL] [Abstract][Full Text] [Related]
33. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.
Hesse C; Rosengren L; Andreasen N; Davidsson P; Vanderstichele H; Vanmechelen E; Blennow K
Neurosci Lett; 2001 Jan; 297(3):187-90. PubMed ID: 11137759
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid tau proteins in status epilepticus.
Monti G; Tondelli M; Giovannini G; Bedin R; Nichelli PF; Trenti T; Meletti S; Chiari A
Epilepsy Behav; 2015 Aug; 49():150-4. PubMed ID: 25958230
[TBL] [Abstract][Full Text] [Related]
35. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.
Green AJ; Giovannoni G; Hall-Craggs MA; Thompson EJ; Miller RF
Sex Transm Infect; 2000 Dec; 76(6):443-6. PubMed ID: 11221126
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
Ogura M; Kagami Y; Suzuki R; Miura K; Uehira K; Kurokawa T; Ito T; Kinoshita T; Emi N; Morishima Y; Kodera Y; Ueda R
Cancer Chemother Pharmacol; 1997; 40 Suppl():S51-7. PubMed ID: 9272135
[TBL] [Abstract][Full Text] [Related]
38. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal Fluid Biomarkers of Neurodegeneration Are Decreased or Normal in Narcolepsy.
Jennum PJ; Østergaard Pedersen L; Czarna Bahl JM; Modvig S; Fog K; Holm A; Rahbek Kornum B; Gammeltoft S
Sleep; 2017 Jan; 40(1):. PubMed ID: 28364448
[TBL] [Abstract][Full Text] [Related]
40. CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics.
Li QX; Varghese S; Sarros S; Stehmann C; Doecke JD; Fowler CJ; Masters CL; Collins SJ
J Clin Neurosci; 2018 Apr; 50():292-293. PubMed ID: 29422367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
